Skip to main content

Bacterial Vectors for the Delivery of Tumor Antigens

  • Protocol
  • First Online:
Book cover Cancer Vaccines

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1139))

Abstract

The use of bacterial vectors, which offer ease of production and efficiency, has become an important mechanism for the delivery of protein antigens to antigen-presenting cells (APCs) in vivo. Proof of concept studies has been carried out utilizing different bacteria in various cancer models with some in clinical trials. Here we described the way to prepare Pseudomonas aeruginosa (P. aeruginosa) vaccines based on a virulence-attenuated strain to test the efficacy of different fragments of a well-known tumor antigen. This protocol could be applied to efficacy studies in murine models of human cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carleton HA (2010) Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks. Yale J Biol Med 83(4):217–222

    PubMed Central  PubMed  Google Scholar 

  2. Shahabi V et al (2010) Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment. Bioeng Bugs 1(4): 235–239

    PubMed Central  PubMed  Google Scholar 

  3. Singh R, Wallecha A (2011) Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic. Hum Vaccin 7(5):497–505

    Article  CAS  PubMed  Google Scholar 

  4. Le Gouellec A et al (2012) Bacterial vectors for active immunotherapy reach clinical and industrial stages. Hum Vaccin Immunother 8(10): 1454–1458

    Article  PubMed Central  PubMed  Google Scholar 

  5. Deane JE et al (2010) Timing is everything: the regulation of type III secretion. Cell Mol Life Sci 67(7):1065–1075

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Epaulard O et al (2008) Optimization of a type III secretion system-based Pseudomonas aeruginosa live vector for antigen delivery. Clin Vaccine Immunol 15(2):308–313

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Derouazi M et al (2008) High-yield production of secreted active proteins by the Pseudomonas aeruginosa type III secretion system. Appl Environ Microbiol 74(11):3601–3604

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Derouazi M et al (2010) Optimal epitope composition after antigen screening using a live bacterial delivery vector application to TRP-2. Bioeng Bugs 1(1):51–60

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Wang, Y., Toussaint, B., Le Gouëllec, A. (2014). Bacterial Vectors for the Delivery of Tumor Antigens. In: Lawman, M., Lawman, P. (eds) Cancer Vaccines. Methods in Molecular Biology, vol 1139. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0345-0_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0345-0_33

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-0344-3

  • Online ISBN: 978-1-4939-0345-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics